Bacillus strains useful against calf pathogens and scours
AssigneeDupont Nutrition Biosciences Aps
InventorsChristopher A. Wehnes, Keith J. Mertz, Mari Ellen Davis, Alexandra Helena Smith, Thomas G. Rehberger
Life of this patent
Estimating the term…
Abstract
The present invention relates to a composition including Bacillus subtilis strains 3A-P4 ATCC Accession No. PTA-6506, 22C-P1 ATCC Accession No. PTA-6508, and LSSA01 NRRL Accession No. NRRL B-50104. The present invention also relates to a method of administering an effective amount of a composition comprising Bacillus subtilis strains 3A-P4 ATCC Accession No. PTA-6506, 22C-P1 ATCC Accession No. PTA-6508, and LSSA01 NRRL Accession No. NRRL B-50104 to a calf.
Claims19
A method comprising administering an effective amount of a composition comprising Bacillus subtilis strains 3A-P4 ATCC Accession No. PTA-6506, 22C-P1 ATCC Accession No. PTA-6508, and LSSA01 NRRL Accession No. NRRL B-50104 to a calf.
A method of providing a benefit to a calf, the method comprising:
- orally administering an effective amount of a composition comprising Bacillus subtilis strains 3A-P4 ATCC Accession No. PTA-6506, 22C-P1 ATCC Accession No. PTA-6508, and LSSA01 NRRL Accession No. NRRL B-50104 to the calf,
- wherein the benefit is selected from at least one of increased weight gain and decreased injectible treatment expenditures when compared to calves not administered the composition, and
- wherein the composition is administered with a milk replacer at a rate of about 2×109 CFU/calf/day, the CFU being a total microbial count of all of the Bacillus subtilis strains, thereby providing the benefit to the calf.
A method of providing a benefit to a calf, the method comprising:
- orally administering an effective amount of a composition comprising Bacillus subtilis strains 3A-P4 ATCC Accession No. PTA-6506, 22C-P1 ATCC Accession No. PTA-6508, and LSSA01 NRRL Accession No. NRRL B-50104 to the calf,
- wherein the benefit is selected from at least one of reducing presumptive C. perfringens shedding, increasing weight gain, reducing medication costs, reducing inflammatory response, and maturing the immune system by stimulating the immune system when compared to calves not administered the composition, and
- wherein the composition is administered with an electrolyte solution at a rate of about 3×109 CFU/dose, the CFU being a total microbial count of all of the Bacillus subtilis strains, thereby providing the benefit to the calf.
Dependencies are inferred from the claim text.